Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nat Cell Biol. 2023 Mar;25(3):404-414. doi: 10.1038/s41556-023-01091-2. Epub 2023 Feb 6.
SLC7A11-mediated cystine uptake suppresses ferroptosis yet promotes cell death under glucose starvation; the nature of the latter cell death remains unknown. Here we show that aberrant accumulation of intracellular disulfides in SLC7A11 cells under glucose starvation induces a previously uncharacterized form of cell death distinct from apoptosis and ferroptosis. We term this cell death disulfidptosis. Chemical proteomics and cell biological analyses showed that glucose starvation in SLC7A11 cells induces aberrant disulfide bonds in actin cytoskeleton proteins and F-actin collapse in a SLC7A11-dependent manner. CRISPR screens and functional studies revealed that inactivation of the WAVE regulatory complex (which promotes actin polymerization and lamellipodia formation) suppresses disulfidptosis, whereas constitutive activation of Rac promotes disulfidptosis. We further show that glucose transporter inhibitors induce disulfidptosis in SLC7A11 cancer cells and suppress SLC7A11 tumour growth. Our results reveal that the susceptibility of the actin cytoskeleton to disulfide stress mediates disulfidptosis and suggest a therapeutic strategy to target disulfidptosis in cancer treatment.
SLC7A11 介导的胱氨酸摄取抑制了铁死亡,但在葡萄糖饥饿下促进了细胞死亡;后者的细胞死亡性质尚不清楚。在这里,我们表明,SLC7A11 细胞在葡萄糖饥饿下的细胞内二硫键异常积累会诱导一种与细胞凋亡和铁死亡不同的新型细胞死亡。我们将这种细胞死亡称为二硫键细胞死亡。化学蛋白质组学和细胞生物学分析表明,SLC7A11 细胞在葡萄糖饥饿下诱导肌动蛋白细胞骨架蛋白中的异常二硫键,并以 SLC7A11 依赖性方式导致 F-肌动蛋白崩溃。CRISPR 筛选和功能研究表明,WAVE 调节复合物(促进肌动蛋白聚合和片状伪足形成)的失活可抑制二硫键细胞死亡,而 Rac 的组成性激活则促进二硫键细胞死亡。我们进一步表明,葡萄糖转运体抑制剂可诱导 SLC7A11 癌细胞中的二硫键细胞死亡,并抑制 SLC7A11 肿瘤的生长。我们的结果表明,肌动蛋白细胞骨架对二硫键应激的敏感性介导了二硫键细胞死亡,并提示了一种针对癌症治疗中二硫键细胞死亡的治疗策略。
Nat Cell Biol. 2023-3
Apoptosis. 2024-10
Trends Cell Biol. 2024-4
Int J Biol Sci. 2024
J Exp Clin Cancer Res. 2023-5-31
MedComm (2020). 2024-6-29
Apoptosis. 2025-9-9
MedComm (2020). 2025-8-31
Curr Issues Mol Biol. 2025-8-14
Nat Rev Mol Cell Biol. 2025-8-22
Nat Chem Biol. 2025-8-22
Transl Oncol. 2025-8-20
Proc Natl Acad Sci U S A. 2022-6-28
Nat Rev Mol Cell Biol. 2021-4